Development of plasma ghrelin level as a novel marker for risk stratification of gastric cancer

Development of plasma ghrelin level as a novel marker for risk stratification of gastric cancer - Development of plasma ghrelin level as a novel marker for risk stratification of gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014496

Enrollment

Registered

2014-07-08

Start date

2015-01-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H. pylori-infected gastritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who visit Keio University Hospital for H. pylori eradication therapy. They are planning to undergo esophagogastroduodenoscopy.

Exclusion criteria

Exclusion criteria: Patients after a laparotomy for the resection of esophagus or stomach

Design outcomes

Primary

Measure	Time frame
Change of plasma ghrelin levels during the H. pylori eradication therapy	—

Countries

Japan

Contacts

Public ContactJuntaro Matsuzaki

Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine

juntaro.matsuzaki@gmail.com03-5363-3914

Outcome results